title: Unrelated cord blood transplantation after myeloablative conditioning in patients with acute leukemia aged between 50 and 55 years.
authors.forename: T
authors.initials: T
authors.lastname: Konuma
authors.forename: J
authors.initials: J
authors.lastname: Ooi
authors.forename: S
authors.initials: S
authors.lastname: Takahashi
authors.forename: A
authors.initials: A
authors.lastname: Tomonari
authors.forename: M
authors.initials: M
authors.lastname: Uchiyama
authors.forename: K
authors.initials: K
authors.lastname: Fukuno
authors.forename: N
authors.initials: N
authors.lastname: Tsukada
authors.forename: T
authors.initials: T
authors.lastname: Iseki
authors.forename: A
authors.initials: A
authors.lastname: Tojo
authors.forename: S
authors.initials: S
authors.lastname: Asano
mesh_terms: D000208:Acute Disease; D001835:Body Weight; D036101:Cord Blood Stem Cell Transplantation / Q000379:methods*; D003561:Cytarabine / Q000627:therapeutic use; D005260:Female; D005312:Fetal Blood / Q000166:cytology; D006086:Graft vs Host Disease; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000628:therapy; D019172:Transplantation Conditioning / Q000379:methods*
chemical_list: D003561:Cytarabine